Provided by Tiger Trade Technology Pte. Ltd.

CSL LIMITED

168.300
-2.900-1.69%
Volume:2.69M
Turnover:422.09M
Market Cap:80.60B
PE:-22.55
High:171.535
Open:170.000
Low:166.280
Close:171.200
52wk High:219.589
52wk Low:90.000
Shares:478.91M
Float Shares:478.91M
Volume Ratio:1.02
T/O Rate:0.56%
Dividend:4.07
Dividend Rate:2.42%
EPS(TTM):-7.465
EPS(LYR):-7.465
ROE:-15.83%
ROA:7.26%
PB:3.90
PE(LYR):-22.55

Loading ...

Company Profile

Company Name:
CSL LIMITED
Exchange:
ASX
Establishment Date:
1916
Employees:
29000
Office Location:
655 Elizabeth Street,Melbourne,Victoria,Australia
Zip Code:
3000
Fax:
61 3 9389 1434
Introduction:
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and Seqirus. The CSL Behring segment offers plasma therapies for the treatment of immunodeficiency, bleeding disorders, hereditary angioedema, Alpha-1 antitrypsin deficiency, and neurological disorders. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza vaccines. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.